Literature DB >> 24795129

Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care.

Vivencio Barrios1, Carlos Escobar2, Alberto Calderón3, Gustavo C Rodríguez Roca4, José Luis Llisterri5, José Polo García6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24795129     DOI： 10.1016/j.rec.2013.07.009

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  9 in total

1.  Impact of an Integral Assistance on the Management of Patients with Chronic Heart Diseases.

Authors:  Román Freixa-Pamias; Pere Blanch Gràcia; Lluïsa Rodriguez Latre; Antoni Oliva Vicedo; Carmen Alonso Permanyer; Pilar Sánchez Chamero; Elisabet Mena Sebastià; Miriam García Bermúdez; Alberto Cabestrero de Diego; Angels González Guardia; Elena Salas González; Carolina Bosch Carabante; José Manuel Depares López; Mireia Sans Corrales; Juan Francisco Pajares Díaz-Meco; Jordi Vericat Garcia; Maria Jesús Megido Badía; Jordi Vilarasau Farre; Maria Rotllan Terradellas; Angel Jover Blanca
Journal:  Eur Cardiol       Date:  2017-12

2.  Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Carlos Escobar; Vivencio Barrios; Gregory Y H Lip; Alpesh N Amin; Ariadna Auladell-Rispau; Marilina Santero; Josefina Salazar; Carolina Requeijo
Journal:  Clin Drug Investig       Date:  2021-10-13       Impact factor: 2.859

3.  Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis.

Authors:  Fuwei Liu; Yupei Zhang; Jun Luo; Yue Zhou
Journal:  Front Cardiovasc Med       Date:  2022-06-01

4.  Satisfaction with oral anticoagulants in patients with atrial fibrillation.

Authors:  Carmen Suárez Fernández; Luis Castilla-Guerra; Jesus Cantero Hinojosa; Josep Maria Suriñach; Fernando Acosta de Bilbao; Juan José Tamarit; José Luis Diaz Diaz; Jose Luis Hernandez; Antonio Pose; Manuel Montero-Pérez-Barquero; Jaume Roquer; Jaime Gállego; José Vivancos; Jose María Mostaza
Journal:  Patient Prefer Adherence       Date:  2018-02-19       Impact factor: 2.711

5.  Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Yuqing Deng; Yifan Tong; Yuanyuan Deng; Le Zou; Shunhui Li; Hui Chen
Journal:  J Am Heart Assoc       Date:  2019-07-16       Impact factor: 5.501

6.  Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies.

Authors:  Zhengbiao Xue; Hao Zhang
Journal:  Stroke       Date:  2019-08-19       Impact factor: 7.914

7.  [Clinical characteristics of patients with atrial fibrillation treated with direct oral anticoagulants attended in primary care setting. The SILVER-AP study].

Authors:  Mariano de la Figuera; Sergio Cinza; Nuria Marín; Isabel Egocheaga; Miguel Angel Prieto
Journal:  Aten Primaria       Date:  2017-07-29       Impact factor: 1.137

8.  [Fine-tuning of antithrombotic therapy in patients with non-valvular atrial fibrillation. The AFINVA register].

Authors:  Daniela Dubois Marques; Vicente Mora Llabata; Julián Pacheco Arroyo; Salvador Gasull Insertis; Manuela Vicente Cañizares; Ildefonso Roldán Torres
Journal:  Aten Primaria       Date:  2017-09-01       Impact factor: 1.137

9.  Prescription of oral anticoagulation in geriatric patients with atrial fibrillation

Authors:  Génesis Ramírez-Prieto; José E Pombo-Bartelt; Guadalupe Rojas-Calderón; José J García-González
Journal:  Arch Cardiol Mex       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.